(Q30573085)

13 November 2017

Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results (English)

1 reference

13 November 2017

0 references

0 references

M P Sormani

1

1 reference

13 November 2017

P D Molyneux

2

1 reference

13 November 2017

C Gasperini

3

1 reference

13 November 2017

F Barkhof

4

1 reference

13 November 2017

T A Yousry

5

1 reference

13 November 2017

D H Miller

6

1 reference

13 November 2017

M Filippi

7

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

13 November 2017

1 reference

13 November 2017

66

1 reference

13 November 2017

4

1 reference

13 November 2017

465-469

1 reference

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

Defining the clinical course of multiple sclerosis: Results of an international survey

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736308

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10201417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10201417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP.66.4.465

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

10201417

1 reference